5 assets in Pseudomonas Aeruginosa Infectious Disease

Therapeutic assets addressing Pseudomonas Aeruginosa Infectious Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Ap-Pa02 Pseudomonas Aeruginosa Infectious Disease	Armata Pharmaceuticals, Inc.	P2	BB (69)
Ceftolozane Pseudomonas Aeruginosa Infectious Disease	Sunshine Coast Hospital and Health Service	P4	BB (65)
Tazobactam Pseudomonas Aeruginosa Infectious Disease	Sunshine Coast Hospital and Health Service	P4	BB (65)
Pseudomonas Aeruginosa-Specific Bacteriophage Mixture, Live Consisting Of 3 Bacteriophages (Ihma-2121771-1, Ihma-2121771-2, Ihma-2121908-1) Pseudomonas Aeruginosa Infectious Disease	BiomX Ltd	P2	BB (64)
Rsp-1502 Pseudomonas Aeruginosa Infectious Disease	Respirion Pharmaceuticals Pty Ltd	P1/2	CCC (52)